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Fungal APSES proteins regulate morphogenetic processes, including filamentation and differentiation. The human fungal
pathogen Candida albicans contains two APSES proteins: the regulator Efg1p and its homologue Efh1p, described here.
Overexpression of EFG1 or EFH1 led to similar phenotypes, including pseudohypha formation and opaque-white
switching. An efh1 deletion generated no phenotype under most conditions but caused hyperfilamentation in an efg1
background under embedded or hypoxic conditions. This suggests cooperation of these APSES proteins in the suppres-
sion of an alternative morphogenetic signaling pathway. Genome-wide transcriptional profiling revealed that EFG1 and
EFH1 regulate partially overlapping sets of genes associated with filament formation. Unexpectedly, Efg1p not only
regulates genes involved in morphogenesis but also strongly influences the expression of metabolic genes, inducing
glycolytic genes and repressing genes essential for oxidative metabolism. Using one- and two-hybrid assays, we further
demonstrate that Efg1p is a repressor, whereas Efh1p is an activator of gene expression. Overall, the results suggest that
Efh1p supports the regulatory functions of the primary regulator, Efg1p, and indicate a dual role for these APSES proteins
in the regulation of fungal morphogenesis and metabolism.
INTRODUCTION
The APSES proteins represent a conserved class of transcrip-
tional regulators that is unique to fungi, regulating cellular
differentiation in the ascomycetes. In Saccharomyces cerevi-
siae, the Phd1 protein induces pseudohyphal growth,
whereas the related Sok2 protein represses this growth form
(Gimeno and Fink, 1994; Ward et al., 1996). The Asm1 pro-
tein promotes ascospore maturation in Neurospora crassa
(Aramayo et al., 1996), and the StuA protein is required for
conidiophore maturation in Aspergillus nidulans (Dutton et
al., 1997). In the human fungal pathogen Candida albicans, the
APSES protein Efg1p controls several morphogenetic pro-
cesses. Efg1p regulates the yeast-to-hypha transition, it is
required for the generation of chlamydospores, and it deter-
mines cell shape during white-opaque switching (Lo et al.,
1997; Stoldt et al., 1997; Sonneborn et al., 1999a,b; Srikantha et
al., 2000). Thus, all known APSES proteins regulate revers-
ible interconversions between a spherical cell type (e.g., a
budding yeast cell, conidiophore, ascospore, and chlamy-
dospore) and an elongated filament (e.g., true hypha,
pseudohypha, an opaque-form cell). In addition, as was
shown for C. albicans Efg1p (Lo et al., 1997), APSES proteins
may be involved in determining virulence of these organ-
isms. However, the mechanisms by which APSES proteins
stimulate cellular differentiation and regulate virulence are
still unknown.
APSES proteins may act both as activators and repressors
of gene expression because they stimulate reversible transi-
tions between spherical and filamentous cells. The induction
of true hyphae in C. albicans, by serum, for example, requires
the presence of Efg1p. This led to the presumption that Efg1
acts as an activator of hypha-specific genes (Lo et al., 1997;
Stoldt et al., 1997). Likewise, the generation of chlamydos-
pores and of the white (yeast-like) cell form depends on
Efg1p as a positive factor (Sonneborn et al., 1999a,b). How-
ever, EFG1 expression is rapidly repressed by negative au-
toregulation after the onset of hyphal development, and it
has been shown that Efg1p, in conjunction with the Sin3p-
dependent histone deacetylase complex, mediates this re-
pression (Tebarth et al., 2003). In addition, EFG1 overexpres-
sion inhibits the formation of true hyphae, inducing
pseudohyphae instead (Stoldt et al., 1997; Tebarth et al.,
2003). An alternative pathway of hypha formation, which is
operative in embedded or microaerophilic conditions, is
repressed by Efg1p (Brown et al., 1999; Sonneborn et al.,
1999a; Giusani et al., 2002). Overexpression of PHD1 in S.
cerevisiae has the same effect as the deletion of its homologue
SOK2 (Gimeno and Fink, 1994; Ward et al., 1996). Pseudohy-
phal growth is induced suggesting that Phd1p is an activator
and Sok2p a repressor of pseudohypha formation and that
the conserved APSES domain does not determine regulatory
specificity. Genetic interactions with elements of a mitogen-
activated protein kinase pathway also support an activator
function of Phd1p (Lo et al., 1997), whereas Sok2p is known
to repress meiosis via a defined regulatory sequence (Shen-
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har and Kassir, 2001). Interestingly, heterologous expression
of Efg1p in S. cerevisiae suggests both repressor and activator
functions for this regulator. EFG1 is able to complement a
sok2 mutation (Shenhar and Kassir, 2001) and at high expres-
sion levels EFG1 induces pseudohyphal growth (Stoldt et al.,
1997).
The multiple functions of Efg1p suggest that it might
interact with coregulatory proteins that modulate its func-
tional specificities. The conserved domain of 100 residues
in APSES proteins contains a basic helix-loop-helix (bHLH)
motif, which might dimerize with another bHLH protein as
a prerequisite for their binding to E-boxes (Nasi et al., 2001).
The bHLH domain of Efg1p has indeed been shown to bind
E-box sequences in vitro (Leng et al., 2001), although in vivo
gene regulation by an E-box motif has not been demon-
strated for any APSES protein. Organisms often contain
pairs of APSES proteins, for example, Phd1p and Sok2p in S.
cerevisiae. Hence, we reasoned that a second APSES protein
might exist in C. albicans and that this protein might modu-
late Efg1p function. Here, we report the identification of an
Efg1p-homologue, Efh1p. We show that Efh1p does not
have an obvious opposing role to Efg1p, as has been re-
ported for Phd1p and Sok2p in S. cerevisiae (Gimeno and
Fink, 1994; Ward et al., 1996). In contrast, Efh1p seems to
modulate some of the functions of the main regulator Efg1p,
which on a molecular level has the activity of a transcrip-
tional repressor. We show that Efg1p and Efh1p not only
regulate fungal morphogenesis but also favor a fermentative
mode of metabolism of C. albicans. These results suggest that
APSES proteins may coordinate morphogenetic and meta-
bolic processes in fungi.
MATERIALS AND METHODS
Strains and Media
Strains are listed in Table 1. To isolate strains homozygous at the MTL locus,
we isolated derivatives able to grow on sorbose as their sole carbon source
(Magee and Magee, 2000). The identity of strains as MTLa was established by
colony polymerase chain reaction (PCR) (primers MTLa-For, 5-TT-
GAAGCGTGAGAGGCTAGGAG-3; MTLa-Rev, 5-ATCAATTCCCTTTC-
TCTTCGATTAGG-3) or as La (primers MTL-For, 5-TTCGAGTACAT-
TCTGGTCGCG-3; MTL-Rev, 5-TGTAAACATCCTCAATTGTACCCGA-
3). Phenotypic switching in homozygous MTL strains was monitored after
pregrowth on modified Lee’s medium (Lee et al., 1975), followed by plating on
SC medium containing 5 g/ml phloxine B and growth at 25°C for 7 d (Miller
and Johnson, 2002). Strains were grown in YPD, SC, SCAA or on supple-
mented SD minimal medium (Sherman et al., 1986); YPS medium is identical
to YPD but contains 2% sucrose as carbon source. S4D medium is SD medium
containing 4% glucose. Serum plates contained 10% horse serum and 2% agar.
Transformation was done by the spheroplast method (Sherman et al., 1986).
To fully induce the PCK1 promoter cells were grown in SCAA medium for
several generations to a final OD600  0.8–1.0 (Stoldt et al., 1997). For growth
in microaerophilic conditions, plates were placed in an anaerobic jar by using
CampyGen bags (Oxoid, Basingstoke, Hampshire, England) to generate an
atmosphere of 6% oxygen. Cells were embedded in YPS-Agar essentially as
described previously (Brown et al., 1999) except that a thin layer of YPS-agar
(8 ml) was poured onto the cell-containing layer. This procedure prevented
spreading of colonies on the agar surface and, by slowing filamentation,
enhanced morphogenetic differences between efg1 single and efg1 efh1 double
mutants.
EFH1 Deletion
The 5region of EFH1 was PCR amplified using primers EFH-FLP1 (5-TGG
GTA CCG GCC TGA TTA GAA TAT GAT TTC CG-3; KpnI, underlined) and
EFH-FLP2 (5-AAC TCG ACC GAG TGA CAA ACT AAT AGC AGAC-3)
and inserted into pUC18 (SureClone; Amersham Biosciences UK), resulting in
plasmid pDB36. Similarly, the 3 region was PCR amplified using primers
EFH-FLP3 (5-ATGCGGCCGCGGCCAATTTTCTTCAAATATTCTGG-3;
NotI, underlined) and EFH-FLP4 (5-CAG AGCTCCTGGACCTTTCCTACCT-
GGATTCTC-3; SacI, underlined) and subcloned to generate pDB37. A 1035 base
pairs NotI/SacI fragment from pDB37 was cloned into NotI/SacI-digested pSFU1
(Morschha¨user et al., 1999) flanking the “Ura-flipper,” resulting in pDB40. A
1043-base pair KpnI fragment from pDB36 was cloned into the KpnI site of pDB40
to generate pDB43. The 4.89-kb SacI fragment from pDB43 was transformed into
strain CAI4 to disrupt the first EFH1 allele. Removal of the FLP-URA cassette was
carried out as described previously (Morschha¨user et al., 1999) and the procedure
was repeated to disrupt the second allele.
The Ura-blaster method was used to make a double efh1 efg1 mutant (Fonzi
and Irwin, 1993). First, the 1-kb KpnI fragment from pDB36 was cloned into
p5921 to generate pSKM49. The 3 region of EFH1 was PCR amplified using
primers SKM-BH1-EFH3-1 (5-ATTGGATCCAATTTTCTTCAAATATTCTG-
G-3) and SKM-BglII-EFH3-2 (5-ATTAGATCTACCTGGATTCTCTCAAC-
3) (BamHI, BglII, underlined) and cloned into pUC18, resulting in pSKM47. A
1-kb BamHI/BglII fragment from pSKM47 was cloned into pSKM49 to con-
struct pSKM50. The SacI-SphI fragment from pSKM50 was used to disrupt
EFH1 alleles in strain HLC67 (Lo et al., 1999). The genotype of each mutant
was confirmed by southern blotting (see Supplemental Data, Figure 1).
EFH1 Plasmids
EFH1 was PCR amplified from genomic DNA by using primers AN1-BHI-
ATG (5-TTGGATCCATGAATGGTATTATGACG-3) and AN3-Stp-BHI (5-
TTGGATCCGTTTATCATAATGTTTTGTG-3 (BamHI site, underlined; coding
region, italics). The PCR fragment was cloned into pUC18 to generate pDB30.
EFH1 overexpression plasmids were constructed by insertion of the EFH1
BamHI-fragment downstream of the PCK1 promoter into the BglII site of
plasmid pBI-1 (Stoldt et al., 1997) or of plasmid pBT-44 to generate pDB35
(URA3) and pBT-145 (ADE2), respectively. To express an HA-tagged version
of Efh1p the BamHI fragment of pDB30 was subcloned first into the BamHI site
of YCpIF17 (Foreman and Davis, 1994) and the HA-EFH1 fusion of this plasmid
(pTD11) was subsequently amplified by primers HAEFH1(ATG)HincII (5-
TTAGTTAACTTATATGAGTCGATACCCATAC-3) and HAEFH(STOP)
HincII(5-TTAGTCAACTTCATAATGTTTTGTGAAC-3) (HincII, underlined).
The HincII-digested PCR-fragment was cloned into the filled-in BglII site of pBI-1
to generate pTD13.
To join the EFH1 promoter to the RLUC reporter, we amplified the 2-kb
genomic region upstream of the EFH1 open reading frame (ORF) by PCR
from genomic DNA of strain SC5314, by using primers EFH1p-5 (5-TTAG-
GATCCAGTTTACCCGAAATCTGTG-3) and EFH1p-3 (5-TTAGGATC-
CGTGAATATACTTATAACGAG-3) (BamHI, underlined). The BamHI-di-
gested PCR fragment was cloned into pUK21; into the SpeI site of the resulting
plasmid pLR3 we inserted the 1-kb NheI-XbaI fragment RLUC fragment of
pRL-Null (Promega, Madison, WI) to construct pLR4. The 3.1-kb SpeI frag-
ment of pLR4 was then inserted into the XbaI site of the URA3-plasmid
p1367/1 (Losberger and Ernst, 1989), resulting in pLR6. pLR6 was integrated
into the genomic EFH1 promoter by digestion with BstI 107I and transforma-
tion of strain CAI4. For comparison an integrating URA3 plasmid, pBT89a,
containing a fusion of the major EFG1 promoter to RLUC (Tebarth et al., 2003)
was cut with HpaI and integrated into the EFG1 promoter of strain CAI4.
Transcriptional Profiling
DNA microarrays containing 6039 C. albicans ORFs of strain SC5314 (98% of
total) in duplicate were purchased from Eurogentec (Seraing, Belgium). Tran-
scriptional profiling was performed on 50 ml of cells grown in YPD or SCAA
medium at 30°C to an OD600 nm  0.5; alternatively, cells were pregrown in
YPD medium at 30°C, starved in water for 1 h at 30°C, and then diluted and
incubated in 10% horse serum at 37°C for 30 min (germ tubes were beginning
to form at this time point). The isolation of total RNA, preparation of Cy3- and
Cy5-cDNA and pairwise hybridization to DNA microarrays were performed
according to Galar Fungail standard operating procedures (www.pasteur.fr/
recherche/unites/Galar_Fungail/) with minor modifications. cDNAs were
purified by the Qiaquick PCR purification kit (QIAGEN, Valenica, CA) and
eluted from columns by twice rinsing with 50 l of water (42°C). The eluate
was concentrated using Microcon-YM30 columns (Millipore, Billerica, MA) to
a volume of 10 l. Ten microliters each of Cy3- and Cy5-labeled cDNA and
herring sperm DNA (10 mg/ml) were mixed, denatured at 95°C for 2 min,
and the quickly chilled on ice. Eighty microliters of hybridization mixture was
added, and the solution was allowed to float onto DNA microarrays slides,
which were covered with a rimmed cover glass (Erie Scientific, Portsmouth,
NH). Slides were placed in a hybridization chamber (Corning, Palo Lato, CA)
and hybridized for 24 h at 42°C by immersion in a water bath. After washing
and drying, microarrays were scanned by a FLA-8000 scanner (Fuji, Tokyo,
Japan) at a resolution of 10 m. Cy3- and Cy5-fluorescence signals were
measured at 532 and 635 nm, respectively. For quantitation of spot and
background fluorescence the program AIDA Array Metrix (Raytest, Pitts-
burgh, PA) was used.
Data from at least three independent experiments using independent
cultures and including one dye-swap experiment were evaluated with the
GeneSpring (Silicon Genetics, Redwood City, CA) software. The Cy3-/
Cy5-ratios were first normalized based on the overall fluorescence inten-
sity and then exported into Excel spreadsheets. Because each ORF was
spotted twice on each array and at least three independent experiments
were carried out, at least six signal intensity ratios reflecting the activity of
a test sample to a reference sample were compared. The data were statis-
tically analyzed using the SAM program (www-stat.stanford.edu/tibs/
SAM), which calculated q-values reflecting variation among the six ratios
(a low q-value indicates a low level of variation). The predicted minimal
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false discovery rate (FDR) value in SAM evaluations in most cases had a
value close to 5% (see Supplemental Data, Tables 1– 8). For comparisons of
data sets, a delta value was chosen corresponding to an FDR value of 5%;
in one case (strain HLC52 grown in YPD medium), 1000 regulated genes
were predicted by this parameter, and a delta value corresponding to a
FDR of 1% was chosen. For Venn diagrams and for gene listings, we
applied more stringent criteria, defining genes as significantly regulated if
they were regulated by at least a factor of 1.5-fold. Cluster analyses and
Venn diagrams were carried out with the GeneSpring program, by using
standard value settings. Gene designations were according to the annota-
tion of the Candida DB Web server (http://genolist.pasteur.fr/Can-
didaDB/).
One- and Two-Hybrid Analyses
Details of the C. albicans one-hybrid system are described elsewhere (Russell
and Brown, unpublished data). Briefly, expression vectors encoding Staphy-
lococcus LexA protein fusions to Efg1p or Efh1p were constructed by PCR
amplification of the EFG1 or EFH1 ORFs and inserting them into CIp-LexA,
resulting in plasmids CIp-LexA-Efg1 and CIp-LexA-Efh1, respectively. The 5
PCR primers used introduced a (Gly)3-Pro-(Gly)2 linker between the amino-
terminal LexA domain and the carboxy terminal domains of Efg1p or Efh1p.
These plasmids were introduced into C. albicans reporter strains that carried
pCR-lacZ (no lexA operator upstream of basic ADH1 promoter) or pCR-
Table 1. Strains and plasmids
Strain or plasmid Genotype or description Reference/source
C. albicans strains
SC5314 prototrophic Fonzi and Irwin (1993)
CAF2-1 Fonzi and Irwin (1993)
CAF2-1/01 as CAF2-1, but MTL/MTL This work
CAF2-1/01-op as CAF2-1/01, but opaque growth form This work
CAI4 ura3imm434/ura3imm434 Fonzi and Irwin (1993)
CAI8 ade2hisG/ade2hisG ura3imm434/ura3imm434 Fonzi and Irwin (1993)
C4/c, C4/d as CAI4, but EFH1/efh1FRT-SAP2p-FLP-URA3-FRT This work
C4/c4, C4/d6 as CAI4, but EFH1/efh1FRT This work
C4/d6-3 as CAI4, but efh1FRT/efh1FRT-SAP2p-FLP-URA3-FRT This work
efh/02 as C4/d6-3, but MTL/MTL This work
efh/02-op as efh/02, but opaque growth form This work
C4/d63-1, C4/d63-3 as CAI4, but efh1FRT/efh1FRT This work
JKC19 as CAI4, but cph1hisG/cph1hisG-URA3-hisG Liu et al. (1994)
HLC52 as CAI4, but efg1hisG/efg1hisG-URA3-hisG Lo et al. (1997)
Bca09-4 as CAI4, but efg1hisG/efg1hisG-URA3-hisG Braun and Johnson (2000)
HLC67 as CAI4, but efg1hisG/efg1hisG Lo et al. (1997)
HLC67[pDB35]a HLC67 carrying pDB35, made MTLa/MTLa This work
HLC74 as CAI4, but efg1hisG/efg1hisG (EFG1) Lo et al. (1997)
HLC54 as HLC52, but cph1hisG/cph1hisG Lo et al. (1997)
H/1.22, H/1.26 as HLC67, but efh1hisG/efh1hisG-URA3-hisG This work
H/1.22-1, H/1.26-1 as HLC67, but efh1hisG/efh1hisG This work
CRC101-103 as CAI8, but containing ADH1-lacZADE2 Russell and Brown, unpublished data
CRC104-106 as CAI8, but containing lexA-ADH1-lacZADE2 Russell and Brown, unpublished data
Red3/6 ade2/ade2, phenotypic switching strain Srikantha et al. (2000)
Transformation vectors
pRC18 URA3-marked CARS2-vector Stoldt et al. (1997)
pBI-1 PCK1-promoter in URA3-marked CARS2-vector Stoldt et al. (1997)
pAPE(2)/ADE PCK1-promoter-EFG1 fusion in CARS2 ADE2-vector Sonneborn et al. (1999b)
pRC2312P-H PCK1-promoter-EFG1 fusion in pBI-1 Stoldt et al. (1997)
pDB35 PCK1-promoter-EFH1 fusion in pBI-1 This work
pBT-4 CARS2 ADE2-vector Sonneborn et al. (1999b)
pBT-44 PCK1-promoter in CARS2 ADE2-vector This work
pBT-145 PCK1-promoter-EFH1 fusion in pBT-4 This work
pTD13 PCK1-promoter-HA-EFH1 fusion in pBI-1 This work
pBT-34 Major EFG1-promoter-LAC4 fusion in CARS2 URA3-vector Tebarth et al. (2003)
p89a Major EFG1-promoter-RLUC fusion in URA3-vector This work
pLR6 EFH1 promoter-RLUC fusion in URA3 vector This work
CIp-LexA URA3-marked integrating vector containing ACT1p-lexA Russell and Brown, unpublished data
CIp-LexA-Efg1 as CIp-LexA, but containing ACT1p-lexA-EFG1 This work
CIp-LexA-Efh1 as CIp-LexA, but containing ACT1p-lexA-EFH1 This work
pGBD-C1 TRP1 vector with GAL4-BD James et al. (1996)
pGAD-C1 LEU2 vector with GAL4-AD James et al. (1996)
pDB17 pGBD-C1 containing EFG1 This work
pDB16 pGAD-C1 containing EFG1 This work
pDB34 pGBD-C1 containing EFH1 This work
pDB33 pGAD-C1 containing EFH1 This work
pSKM69 pGBD-C1 containing efh1N1 This work
pSKM68 pGAD-C1 containing efh1N1 This work
pCS5 pGBD-C1 containing efh1N2 This work
pCS6 pGAD-C1 containing efh1N2 This work
pCS7 pGBD-C1 containing efh1N3 This work
pCS8 pGAD-C1 containing efh1N3 This work
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OplacZ (containing lexA operator) integrated into the ade2::hisG locus (Russell
and Brown, unpublished data).
For two-hybrid experiments, plasmids encoding protein fusions to the
Gal4p-DNA-binding domain (BD) or the Gal4p-transcriptional activation do-
main (AD) were constructed by inserting appropriate DNA fragments into
plasmids pGBD-C1 and pGAD-C1, respectively (James et al., 1996). The 1.5-kb
EcoRI/BamHI fragment of pUC19-EFG1 was used to construct EFG1 expres-
sion vectors pDB17 (BD) and pDB16 (AD). Similarly, the 2.1-kb BamHI frag-
ment of pDB30 was used to construct EFH1 vectors pDB34 (BD) and pDB33
(AD). Subfragments of the pDB30 insertion fragment also were cloned into
pGBD-C1 or pGAD-C1 to test the effect of C-terminal shortening of Efh1p: (a)
deletion efh1N1: the BamHI-BglII fragment generated pSKM69 (BD) and
pSKM68 (AD); (b) deletion efh1N2: the BamHI-PstI fragment generated pCS5
(BD) and pCS6 (AD); and (c) deletion efh1N3: the BamHI-ScaI fragment
generated pCS7 (BD) and pCS8 (AD). Plasmids were transformed pairwise
into strain PJ69–4A (MATa trp1-901 leu2,3-112 ura3-52 his3-200 gal4 gal80
LYS2::GAL1-HIS3 GAL2-ADE2 met2::GAL7-lacZ) and assayed for prototrophy
for histidine and adenine, as well as for -galactosidase (LacZ) activity (James
et al., 1996).
Reporter Gene Assays
RLUC activity was determined using the Dual-Luciferase Reporter Assay
(Promega). To 50–100 l of LARII reagent 10 l of crude extract was added
and after 10 s at room temperature, 50–100 l of Stop&Glo reagent was used
to stop the reaction. Immediately afterward, light emission was assayed in a
luminometer (Fluorskan Ascent FL; Labsystem, Helsinki, Finland). -Galac-
tosidase activity in cells, expressed in Miller units, was determined by stan-
dard procedures on plates containing X-Gal or in liquid by using O-nitrophe-
nyl -d-galactopyranoside (ONPG) as indicators (Miller, 1972).
RESULTS
EFH1 Is Related to EFG1
Analysis of C. albicans genomic sequences (http://www.
sequence.stanford.edu/group/candida) by using the
BLAST algorithm revealed a single EFG1 homologue
(orf6.4659), which we named EFH1 (EFG1 homologue). The
EFH1 ORF is 45% identical to the EFG1 ORF, and it encodes
a hypothetical protein of 720 residues (81,373 Da), which is
23% identical to the 552 aa-Efg1 protein. Efh1p displays high
similarity to Efg1p and other APSES proteins within a do-
main encompassing residues 443–546 (65% amino acid se-
quence identity) (Figure 1). This APSES domain contains a
bHLH subdomain from residues 480–537. Efh1p lacks the
putative protein kinase A phosphorylation target in the
APSES domain corresponding to residue 206 in Efg1 (Bock-
mu¨hl and Ernst, 2001). Outside the APSES domain, Efh1p
and Efg1p share little sequence similarity except for the
occurrence of glutamine-rich stretches. In Efh1p, these occur
at residues 85–102 and 200–223. A unique feature of Efh1p is
a stretch of acidic residues between residues 615 and 643.
Northern analyses revealed two low abundance EFH1
transcripts of 2.5 and 2.7 kb (our unpublished data), indi-
cating that EFH1 is expressed at low levels. To compare the
transcriptional activities of EFH1 and EFG1 loci, we inte-
grated the RLUC reporter in place of the respective ORFs, by
chromosomal integration of plasmids pLR6 and p89a to
generate EFH1p-RLUC and EFG1p-RLUC fusions, respec-
tively. Luciferase activities were 10-fold lower for the
EFH1p-RLUC fusion compared with the EFG1p-RLUC fusion
during growth in minimal medium (0.003 	 0.001 vs.
0.025 	 0.002 relative light units/g protein, respectively).
This suggests that the EFH1 promoter has an10-fold lower
activity compared with the EFG1 promoter under these con-
ditions.
Phenotypes of efh1 Mutants
A homozygous efh1/efh1 mutant was constructed to examine
the function of EFH1 (strain C4/d6-3). In addition, heterozy-
gous EFH1/efh1 strains were obtained in this process (strains
C4/c, d). The growth characteristics of these mutants were
identical to the isogenic wild-type strain under numerous
conditions, and no obvious antifungal resistance or stress
phenotypes were detected. The cellular morphologies of efh1
Figure 1. APSES proteins in C. albicans. (A)
Schematic structures of Efg1 and Efh1 pro-
teins. The location of bHLH and APSES do-
mains and of regions enriched in the indi-
cated amino acids is shown. (B) Comparison
of APSES proteins. The arrow indicates the
position of a potential phosphorylation site in
Efg1p and Sok2p, which is absent in Efh1p
and Phd1p. Proteins from the following spe-
cies are compared: C. albicans (Efh1p/Efg1p),
S. cerevisiae (Phd1p/Sok2p), A. nidulans
(StuA), N. crassa (Asm1), and P. marneffei
(StuA). Black boxes, identical residues; gray
boxes, similar residues in a subset of APSES
proteins.
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mutants were similar to the wild-type strain, in contrast to
the rod-like shape of efg1 mutants (Figure 2A). Hyphal de-
velopment was normal on solid and in liquid media (Lee’s,
Spider, low-nitrogen and serum-containing media) and un-
der embedded conditions (see below). In addition, chlamy-
dospore formation was normal in cells lacking Efh1p. To test
whether the inactivation of Efh1 effected phenotypic switch-
ing, we measured white-opaque switching in the homozygous
MTL/MTL efh1/efh1 strain efh/02. Isogenic wild-type
and efh1 cells switched from white to opaque at a frequency of
5% as expected (Miller and Johnson, 2002). Likewise,
opaque cells that arose in this experiment frequently
switched back to the white form (our unpublished data).
Thus, switching occurred normally in efh1 cells, in contrast
to efg1 cells that seemed locked in an opaque-like state (Son-
neborn et al., 1999b). Collectively, our data indicate that an
efh1 mutation does not influence the various morphogenetic
processes that are strongly affected by an efg1 mutation
(morphogenesis and phenotypic switching).
Sok2p and Phd1p have opposing regulatory functions in
S. cerevisiae. Hence, we examined the possibility of genetic
interactions between EFH1 and EFG1 by comparing the
phenotypes of efh1 and efg1 single mutants with efh1 efg1
double mutants (strains C4/d63-1, HLC67, and H/1.22).
During growth in standard hypha-inducing conditions the
efh1 efg1 double mutant showed similar defects in hypha and
chlamydospore formation to an efg1 single mutant, generat-
ing the rod-like cells typical of an efg1 mutant (our unpub-
lished data).
We further tested morphogenesis under hypoxic or em-
bedded conditions, in which Efg1p seems to repress a
poorly defined alternative signaling pathway regulating
hypha formation (Brown et al., 1999; Sonneborn et al.,
1999a). When C. albicans cells were grown embedded in
agar at 24°C, efg1 cells displayed increased hypha forma-
tion compared with isogenic wild-type or efh1 cells (Fig-
ure 2B). In contrast, efg1 cells did not form hypha in a jar
generating microaerophilic conditions (6% oxygen),
whereas efh1 cells formed hyphae like the wild-type par-
ent under these conditions (Figure 2B).
We observed a synthetic phenotype between efh1 and efg1
mutations with regard to filament formation during growth
under some embedding conditions (see MATERIALS AND
METHODS). Compared with the efh1 and efg1 single mu-
tants, the efh1 efg1 double mutants formed colonies with
lateral hyphae faster and filamentation was more extensive.
Furthermore, under microaerophilic conditions the efg1 efh1
double mutant filamented vigorously, like wild-type and
efh1 cells, whereas the efg1 single mutant did not filament;
also, in these conditions, an efg1 mutation did not block
filamentation occurring in an cph1 genetic background. (Fig-
ure 2B). We interpret this to mean that the simultaneous
inactivation of Efg1p and Efh1p (or Cph1p) derepresses an
alternative pathway of filamentation in an oxygen-depen-
dent manner. Under aerobic conditions Efg1p is required to
form hyphae. However, this requirement for Efg1p is re-
leased by the additional inactivation of Efh1p, but only
under low-oxygen or embedding conditions. In more hy-
poxic conditions (i.e., in a stream of nitrogen), however, the
alternative pathway was almost fully induced in an efg1
mutant, and its excessive filamentation was not greatly in-
creased by an efh1 mutation (our unpublished data). Thus, it
seems that an efh1 phenotype is observed especially in in-
termediate conditions, in which neither the standard nor the
alternative pathways of filamentation are fully induced.
EFH1 Overexpression Phenotypes
The deletion of the EFH1 locus alone had no obvious effect
upon morphogenesis in C. albicans. Hence, we investigated
whether EFH1 overexpression would have an effect on this
Figure 2. Morphological phenotypes of efh1
and efg1 mutants. (A) Cellular morphology of an
efh1 mutant (strain C4/d63-1) and an efg1 mu-
tant (strain HLC52) visualized by phase contrast
microscopy. (B) Comparison of colony pheno-
types. Strains CAF2-1 (wt), C4/d63-1 (efh1),
HLC52 (efg1), H/1.22 (efh1 efg1), HLC54
(efg1 cph1), and JKC19 (cph1) were grown for
5 d at 24°C embedded in agar or at 30°C in a jar
generating microaerophilic conditions or aerobi-
cally.
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process. Strains expressing EFH1 under the regulatable
PCK1 promotor grew as regular or slightly elongated yeast
cells under repressing conditions, but they formed
pseudohyphae after induction of the PCK1 promoter. These
cells budded apically and had calcofluor white-stainable
constrictions at cellular junctions (Figure 3A). Interestingly,
EFH1 overexpression did not lead to pseudohyphal forma-
tion in an efg1 genetic background (HLC67) (Figure 3A, c).
However, EFG1 overexpression produced pseudohyphae in
both an efg1 and an efh1 background (our unpublished data).
Thus, although overexpression of either EFG1 or EFH1 in-
duces pseudohyphal development, Efg1p would seem to be
the main regulator of this process, because the EFH1-over-
expression phenotype requires the presence of Efg1p.
We showed previously that EFG1 overexpression blocks
the formation of true hyphae (Tebarth et al., 2003). Interest-
ingly, EFH1-overexpressing cells generated the same pheno-
type: pseudohyphal cells incapable of forming true hyphae
in response to serum (Figure 3B). In contrast, cells express-
ing EFH1 at low levels did respond to serum, forming
strongly aggregating germ tubes and true hyphae. Hypha
production was still blocked in efg1 cells overexpressing
EFH1, indicating that the requirement for Efg1p cannot be
bypassed by EFH1 overexpression.
EFG1 overexpression causes rapid phenotypic switching
from opaque to white cells (Sonneborn et al., 1999b). To test
whether EFH1 overexpression affects this process, we exam-
ined the behavior of opaque Red3/6 cells carrying a PCK1p-
EFH1 fusion (pBT-145) on media containing phloxine B
(which stains opaque colonies pink, whereas white-form col-
onies are white). All of the cells formed pink colonies on
PCK1p-repressing S4D-medium indicating that the opaque
form was stable at low EFH1 expression levels (Figure 3C).
Control transformants grown on SCAA medium remained
purely opaque. In contrast, EFH1 overexpression on SCAA
medium generated mostly white colonies, although some
pink spots indicative of opaque cells did remain (Figure 3C).
Thus, EFH1 overexpression was able to induce the opaque to
white conversion, whereas it did not affect the reverse
switching process (white-opaque) (our unpublished data). To
test whether forced opaque to white conversion was depen-
dent on Efg1p, we overexpressed EFH1 in the MTLa efg1-
homozygous strain (HLC67[pDB35]a), which on phloxine
plates formed opaque-like pink colonies (Sonneborn et al.,
1999b). In this case, overexpression of EFH1 did not give rise
to white form colonies. We conclude that opaque to white
switching, which is triggered by EFH1 overexpression, is
dependent on Efg1p.
Transcriptomes of Strains Lacking APSES Proteins
Transcript profiling was used to examine further the roles of
the APSES proteins in C. albicans. DNA microarrays carrying
an almost complete set of C. albicans ORFs were used for
these experiments, in which the transcriptomes of efg1 and
efh1 mutants were compared with wild-type cells under
identical growth conditions. Genes that displayed reproduc-
ible and statistically significant changes in expression rela-
tive to wild-type cells were identified after exposure to
hypha-inducing or -noninducing growth conditions (Figure
4A). Lists of all genes that displayed significant regulation
by Efg1p and Efh1p are provided as supplemental data
(Supplemental Data, Tables 1–6).
To explore the functions of the APSES proteins under
conditions that promote growth in the yeast form, we com-
pared the transcriptomes of wild-type and mutant strains in
YPD medium at 30°C. The deletion of EFG1 altered the
expression of 283 genes by 1.5-fold, with 100 genes being
up-regulated and 183 being down-regulated. Only nine
genes were affected by the deletion of EFH1 (8 genes were
up- and 1 was down-regulated) (Figure 4A). Only two genes
of unknown function (IPF4696 and IPF4328) were com-
monly affected in both single mutants. The simultaneous
deletion of EFG1 and EFH1 showed a transcriptional pattern
that overlapped with that of efg1 single mutants (49 genes).
However, a new subset of 63 genes was affected in the efg1
efh1 double mutant that was not affected in the efg1 single
mutant. This is consistent with the existence of synthetic
interactions between EFG1 and EFH1. These results indicate
Figure 3. Phenotypes of EFH1 overexpression. (A) Generation of
pseudohyphae. A pDB35-transformant of strain CAI4 (a and b) or of
efg1 mutant HLC67 (c) was grown in SCAA medium before micros-
copy. Intercellular junctions are visualized by calcofluor white flu-
orescence (b). (B) Inhibition of true hypha formation. A pDB35-
transformant of strain CAI4 was pregrown in SCAA medium (a) or
SD medium (b) and shifted to the same medium containing 10%
serum and grown for 60 min at 37°C. At low microscopic magnifi-
cation (bottom photographs), the aggregate-formation by hyphae of
SD-grown cells is visible. (C) Promotion of opaque to white pheno-
typic switching. The opaque form of strain Red3/6 was transformed
with pBT-145 (PCK1p-EFH1) or with control vector pBT-44 (PCK1p)
and transformants were grown at 25°C on PCK1p-repressing S4D or
-inducing SCAA medium containing phloxine B. Note the speckled
appearance of pBT-145 transformants on SCAA plates consisting
mainly of the white form but containing red sectors indicative of the
opaque form.
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that under standard growth conditions Efg1p (but not
Efh1p) has an important role in gene regulation.
Categorization of the regulated genes according to their
functional categories of the MIPS database (http://
mips.gsf.de/genre/proj/yeast/searchCatalogFirstAction.
do?dbCYGD) revealed that deletion of EFG1 alone or in
combination with an EFH1 deletion had a striking effect on
carbon metabolism (Figures 4B and 5; Supplemental Data,
Table 2). Transcript levels for almost all glycolytic genes
(e.g., FBA1, PFK1, and ENO1) and for genes involved in the
metabolism of reserve sugars trehalose and glycogen (e.g.,
TPS2, TPS3, and GSY1) were reduced in an efg1 mutant by a
factor of 2 or 3. In addition, transcript levels for several citric
acid cycle enzymes (e.g., FUM12 and KGD1), enzymes of the
mitochondrial ATPase complex, and glycine and formate
catabolic enzymes were increased (Figure 6). In contrast, the
inactivation of Efh1p affected few glycolytic genes only
slightly (Figure 5 and Supplemental Data, Table 2).
To confirm the transcriptional profiling data, we per-
formed Northern analysis on a selection of Efg1p-regulated
genes (Figure 6). The results confirmed the reduced levels of
two glycolytic transcripts in the efg1 mutant (FBA1 and
PFK1) and the increased levels of the HHF22 and FUM12
transcripts in the efg1 mutant (Figure 6E).
To verify the biological consequences of a presumed re-
duced glycolytic flux in efg1 strains, we compared its growth
to a wild-type strain in the presence of antimycin A, which
blocks ATP production by the respiratory chain. We indeed
observed that two independently constructed efg1 mutants
(strains Bca09-4 and HLC52) grew similar to the wild-type in
medium without antimycin A, but in the presence of anti-
mycin A were retarded in growth (Figure 7). Insertion of a
single wild-type copy of EFG1 into the mutant background
of strain HLC52 (strain HLC74) partially increased antimy-
cin A-resistance as expected from a reduced EFG1 gene
dosage (Fu et al., 2002). To confirm the enhanced antimycin
A-sensitivity of the efg1 mutants, we also performed a mix-
ing experiment, in which the wild-type CAF2–1 and the efg1
mutant HLC52 were grown in the same YPD culture. At the
starting OD600 nm of 0.05 efg1 mutant cells amounted to 60%
of cells in the mixed culture and slightly decreased to 40%
after 12 h of growth (final OD600 nm  12). In contrast,
growth in the presence of 100 M antimycin A for 12 h led
to an strong decrease of efg1 mutant cells to 10% (final OD600
nm  5). These results are consistent with reduced glycolytic
ATP-production in efg1 mutants, suggesting a dual function
of Efg1p in morphogenesis and metabolism.
Other genes regulated by Efg1p under noninducing con-
ditions include genes encoding histones, stress response-
proteins membrane transporters, and putative cell wall pro-
teins (Figure 5). Another interesting group of genes that
seems to be repressed by Efg1p encode for putative tran-
scriptional activators (CTA21, CTA24, and CTA26), raising
the possibility that Efg1 is a global regulator of gene expres-
sion. The highest Efg1p-dependent regulation (30-fold up-
regulation) was observed for a putative multidrug resistance
protein (IPF14540) (Supplemental Data, Table 1).
Transcriptomes during Morphogenesis
In a previous study, the transcriptomes of wild-type and efg1
strains were compared after growth in hypha-inducing con-
ditions for several generations (Nantel et al., 2002). In this
study, we focused upon the identification of genes whose
expression depends on the APSES proteins during an early
stage of hyphal development. We generated transcriptional
profiles for efg1 and efh1 cells exposed to serum for only 30
min at 37°C, by using a wild-type strain (CAF2–1) as refer-
ence. At this time point 50% of wild-type cells showed
short protrusions, which developed into germ tubes and
ultimately formed hyphae during prolonged incubation.
Under these hypha-inducing conditions, the deletion of
EFG1 caused major changes in the transcriptome. The ex-
pression of 243 genes was affected by a factor of 1.5 in efg1
cells compared with wild-type cells. In contrast, the deletion
of EFH1 had a relatively small effect, affecting the expression
of 39 genes (Figure 4A). However, 58 new genes were af-
fected by the efg1 efh1 double mutant, supporting the idea
that EFG1 and EFH1 interact synthetically to regulate the
expression of some C. albicans genes.
Again, glycolytic genes were expressed at lower levels in
cells lacking Efg1p (Figures 4B and 5). However, in contrast
to the analysis under yeast growth conditions, genes in-
volved in oxidative metabolism were not upregulated in efg1
cells during hyphal development (e.g., CIT1, MDH1, KGD1,
FDH3.3F, FDH4.3F, and FDH12) (Figure 5C). Thus, Efg1p
seems to repress these genes under noninducing conditions,
but not during hyphal development. This pattern might be
due to the lack of glucose in the inducing medium used.
Figure 4. Transcript profiles of C. albicans mutants lacking the
APSES proteins Efg1p or Efh1p. (A) Venn diagrams of genes regu-
lated by Efg1p and Efh1p. The wild-type strain CAF2–1 was used as
reference for the efg1 mutant (HLC52), the efh1 mutant (C4/d6-3)
and the efg1 efh1 double mutant (H/1.22), which were all grown in
identical conditions: YPD/30°C (non-inducing) or for 30 min in
hypha-inducing YP serum, 37°C. (B) Functional categories of genes
regulated by Efg1p in the indicated conditions.
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Therefore, Efg1p-dependent repression of genes involved in
oxidative metabolism might require the presence of glucose.
Transcript Profiling of EFG1- or EFH1-Overexpression
To identify genes that are regulated by high levels of APSES
proteins, we performed transcript profiling of C. albicans
cells overexpressing EFG1 (pRC2312P-H) or EFH1 (pDB35)
from the PCK1 promoter. Cells containing the empty expres-
sion vector (pBI-1) were used as reference. The transcript
levels of 85 and 81 genes were affected by elevated EFG1 or
EFH1 expression, respectively (Figure 8; Supplemental Data,
Tables 7 and 8).
Among the 85 genes regulated by EFG1 overexpression,
53 genes were down-regulated (1.5- to 3.5-fold) and 32 genes
were up-regulated (1.5- to 19-fold). The up-regulated genes
encode cell wall proteins such as Hwp1p, Als10p, Rbt5p,
Ece1p, and Phr1p, which are known to be associated with
filamentous growth in C. albicans (Birse et al., 1993; Bailey et
al., 1996; Fonzi, 1999; Sharkey et al., 1999; Braun and Johnson,
2000; Braun et al., 2000; Lane et al., 2001) (Figure 5F). The
DDR48 gene, encoding a stress protein, and IPF1222 (SOD5),
encoding a hypha-specific superoxide dismutase (Nantel et
al., 2002), also were up-regulated. Most of these genes make
up the overlap of 14 genes reduced by the absence of Efg1p
in inducing conditions, and induced by EFG1 overexpres-
sion (Figure 8A). Whereas EFG1 down-regulated a majority
of genes, EFH1 overexpression up-regulated most genes (53
up-regulated and 28 down-regulated genes). In agreement
with the related phenotypes generated by EFG1 and EFH1
overexpression, the corresponding transcriptional profiles
were similar (Figure 8B). Especially filament-specific genes
such as HWP1 and ECE1 but also metabolic genes such as
Figure 5. Transcriptional regulation of individ-
ual genes by Efg1p or Efh1p. Representative
genes responsible for specific cellular functions
are grouped and their regulation in efg1 and efh1
single and double mutants and strains overex-
pressing EFG1 or EFH1 relative to the CAF2-1
wild-type strain is listed. Genes involved in gly-
colysis (A), reserve sugar metabolism (B), citric
acid cycle (C), histone biosynthesis (D), stress
response (E), and cell wall biosynthesis (F) are
compared. Numbers next to gene designations
indicate the relative transcript levels of such
genes (transcript level of individual gene relative
to the average level of all genes) in the wild-type
strain CAF2-1, grown in YPD (30°C) and YP se-
rum (37°C), respectively.
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ADH5 and MET6 were up-regulated by EFG1 and EFH1
overexpression (Supplemental Data, Figure 4). These exper-
iments also revealed that in general, a different set of genes
is regulated during the formation of true hyphae (dependent
on Efg1p) compared with pseudohyphal formation (trig-
gered by EFG1 overexpression). Clearly, significant molec-
ular differences exist between these morphological states.
Activity of Efg1p and Efh1p in One- and Two-Hybrid
Assays
Efg1p is assumed by some to act as a transcriptional activa-
tor on the basis that the expression of hypha-specific genes
depends upon Efg1p. However, other data suggest that Efg1
acts as a repressor. Therefore, we performed one- and two-
hybrid assays to test directly whether the APSES proteins act
as transcriptional activators or repressors.
In a first set of experiments, we used a recently developed
one-hybrid assay, which allows an assessment of transcrip-
tional regulatory activity in C. albicans (Russell and Brown,
unpublished data). In these experiments LexA fusions to
Efg1p or Efh1p were tested for their ability to repress or
activate a lacZ reporter gene. This reporter was transcribed
by a basal ADH1 promoter fused to a lexA operator (Figure
9A, top). Transformants expressing lexA alone showed a
basal level of -galactosidase activity as indicated by blue
staining on X-gal plates (Figure 9A, bottom). In contrast,
-galactosidase activity was significantly reduced in cells
producing a LexA-Efg1 fusion. This reduction did not occur
in a reporter lacking the lexA operator. Hence, Efg1p seems
to act as a transcriptional repressor in C. albicans. Further
experiments showed that the repressing function of the
LexA-Efg1p was not affected by hypha-inducing stimuli,
such as 10% serum or growth in microaerophilic conditions.
In contrast to Efg1p, a LexA-Efh1p fusion significantly acti-
vated lacZ expression (Figure 9A, bottom), suggesting that
Efh1 acts as a transcriptional activator.
In a second set of experiments, we performed standard
two-hybrid assays in S. cerevisiae to examine the regulation
and possible interactions of APSES proteins. For this pur-
pose, we tested fusions of Efg1p or Efh1p to the Gal4p
DNA-binding (BD) or activating domains (AD). In contrast
to the one-hybrid assays in C. albicans, we found that BD-
Efg1p-fusions did not influence lacZ reporter expression in
S. cerevisiae. This suggests a requirement for C. albicans-
specific components in the repressor function of Efg1p. In
contrast, Efh1p-BD-fusions activated the lacZ reporter sig-
nificantly (Figure 9B), which was consistent with the above-
mentioned one-hybrid data obtained with C. albicans.
A C-terminally truncated Efh1p comprising 432 resi-
dues (N1) also activated the reporter gene in S. cerevisiae.
However, further truncated versions retaining 275 or 159
residues (N2 and N3) were inactive (Figure 9B). These
results suggested that Efh1p contains an activation do-
main between residues 275 and 432. An AD-Efh1p fusion
did not activate the reporter, presumably because binding
of the fusion protein to the promoter did not occur. How-







ENO1 CA3874 Enolase I 0.66 0.60 0.96
FBA1 CA5180 Fructose-bisphosphate aldolase 0.37 0.46 0.99
GLK1 CA0263 Aldohexose specific glucokinase 0.40 0.54 0.80
GPM1 CA4671 Phosphoglycerate mutase 0.40 0.56 0.99
PFK1 CA1834 Phosphofructokinase, alpha subunit 0.46 0.53 0.97
PFK2 CA3112 Phosphofructokinase, beta subunit 0.41 0.65 0.93
PGI1 CA3559 Glucose-6-phosphate isomerase 0.50 0.64 0.96
TPI1 CA5950 Triose phosphate isomerase 0.44 0.58 0.82
HXK2.3F CA0127 Hexokinase II 0.36 0.49 0.76
Reserve
carbohydrates
TPS2 CA5066 Threalose-6-phosphate phosphatase 0.45 0.83 0.89
TPS3.3 CA5505 Trehalose-phosphate synthase, regulatory subunit 0.41 0.49 0.92
IPF8321 CA2938 Initiator of glycogen synthesis 0.41 0.53 1.01
GSY1 CA5467 Glycogen synthase 0.45 0.51 1.04
GPH1 CA5206 Glycogen phosphorylase 0.35 0.57 0.98
RHR2 CA5788 DL-glycerol phosphatase 0.23 0.60 1.16
Citric acid
cycle
ACC1 CA5816 Acetyl-coenzyme-A carboxylase 1.5 1.42 1.08
ACH1 CA0345 Acetyl-coenzyme-A hydrolase 2.3 1.82 1.10
FUM12.3F CA4351 Fumarate hydratase, 3-prime end 3.1 1.60 1.10
FUM12.5F CA4349 Fumarate hydratase, 5-prime end 2.1 1.57 1.05
GDH3 CA1579 NADP-glutamate dehydrogenase 2.5 0.79 1.07
IPF4401 CA0903 Succinate dehydrogenase 1.7 0.99 1.24
KGD1 CA3149 2-oxoglutarate dehydrogenase 2 1.22 1.15
MDH1 CA5164 Mitochondrial malate dehydrogenase precursor 1.6 1.21 1.20
SDH12 CA2470 Succinate dehydrogenase 1.5 1.08 1.09
ACS2 CA2858 Acetyl-coenzyme-A synthetase 1.51 1.5 1.02
Expression of genes in an efg1 mutant (HLC52), an efh1 mutant (C4/d6-3) and an efg1 efh1 mutant (H/1.22) relative to the wild-type CAF2-1.
Cells were grown in YPD medium at 30°C prior to transcriptional profiling.
APSES Proteins in C. albicans
Vol. 15, July 2004 3175
Figure 6. Regulation of genes involved in carbon metabolism by Efg1p. Genes regulated by Efg1p are involved in glycolysis (A), citric acid
cycle (B), ATP biosynthesis (C), and glycin degradation (D) (genes up-regulated by Efg1p, green; genes down-regulated by Efg1p, red). (E)
Northern blots on 30 g of RNA of strain CAF2-1 (wt) and strain HLC52 (efg1), by using probes for the indicated genes. Equal loading was
verified by ethidium-bromide staining of rRNA (rRNA).
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ever, a strain containing both the BD-Efh1p fusion and the
AD-Efh1p fusion contained twice the activity compared
with a strain only containing a BD-Efh1p, suggesting
homodimerization of Efh1p. This effect also was observed
for the N1- and N2-proteins, but not the N3-truncated
forms suggesting that N2 proteins are still able to dimer-
ize and that a putative dimerization domain may be lo-
cated between residues 159 and 275 of Efh1p. Similar
experiments for the Efg1 protein did not reveal a ho-
modimerizing activity for this transcriptional regulator
nor heterodimerization with Efh1p.
From these experiments, we conclude that Efg1p and
Efh1p have different regulatory potential. Efh1p functions as
a transcriptional activator, as demonstrated in both C. albi-
cans and S. cerevisiae. In contrast, Efg1p functions as a re-
pressor, a function that for unknown reasons is only de-
tected in the homologous host C. albicans. Furthermore,
Efh1p but not Efg1p is able to form homodimers. As ex-
pected, the activation and dimerization domains of Efh1p
are in regions that lack significant homology between these
APSES proteins.
DISCUSSION
The availability of the complete C. albicans genomic se-
quence has allowed us to identify the complete set of APSES
proteins in this organism, consisting of Efg1p and Efh1p. As
a result, we were able to perform a comprehensive pheno-
typic and transcriptional analysis of APSES proteins, and in
particular we were able to assess the relative contributions
of both proteins to growth and morphogenesis. Further-
more, we examined functional interactions between both
proteins and their cellular roles in C. albicans. This has al-
lowed us to compare their functions to the APSES proteins
of S. cerevisiae, which represent the only other known com-
plete set of APSES protein in a fungal species.
Overexpression of both EFG1 and EFH1 induces
pseudohyphal growth and represses the formation of true
hyphae (Stoldt et al., 1997; Tebarth et al., 2003). At normal
expression levels, both proteins cooperate to repress an al-
ternative pathway of true hypha formation, which only
seems to be operative in embedded or microaerophilic con-
ditions. The function of the alternative pathway of filamen-
tation in C. albicans is yet unknown, but it could promote
morphogenesis in deep tissues or in phagocytic vacuoles
when oxygen becomes limiting and/or cells are surrounded
by an extracellular matrix. Our data suggest that the APSES
proteins down-regulate this alternative morphogenetic
pathway, thereby preventing filamentation under these con-
ditions. On the other hand Efg1p is positively required for
maintenance of the yeast growth form. In the absence of
Efg1, cells change to a rod-like (opaque-like) form (Sonneborn
et al., 1999b; Srikantha et al., 2000). Furthermore, Efg1p is
required for the competence of yeast cells to undergo hyphal
morphogenesis in standard (aerobic) conditions (Stoldt et al.,
1997; Lo et al., 1997). Thus, Efg1p may have both activator
and repressor functions in C. albicans, unlike APSES proteins
in S. cerevisiae. Our one- and two-hybrid analyses confirmed
a repressor function for Efg1p and an activator function for
Efh1p, which had the ability to form homodimers in these
tests. As expected, activation and homodimerization do-
mains of Efh1p were mapped to regions outside of the
conserved APSES domain.
Sequence comparisons reveal that Efh1p is more similar to
the activator Phd1p, whereas Efg1p is more similar to the
repressor Sok2p. For example, a potential PKA phosphory-
lation site is present in the APSES domains of Efg1p and
Sok2 (RVT), but it is absent in Efh1p and Phd1 (KVA448 and
RVI, respectively) (Bockmu¨hl and Ernst, 2001). A direct role
of Efg1p as a repressor was shown recently by its role as a
negative autoregulator at the EFG1 promoter (Tebarth et al.,
2003). The apparent repressor function of Efh1p in embed-
ded/hypoxic conditions may in fact reflect Efh1p-dependent
activation of Efg1p repressor activity, or of EFG1 expression
under these conditions. Such an indirect role for Efh1p is
Figure 7. Supersensitivity of efg1 mutants to antimycin A. Wild-
type strain CAF2-1 and efg1 mutants HLC52 and Bca09-4 (efg1), as
well as an efg1 mutant reconstituted with EFG1 (HLC74) were
grown in YPD and a series of tenfold dilutions was spotted on YPD
agar containing 10 g/ml antimycin A and grown at 30°C for 3 d.
Figure 8. Genes regulated by EFG1 or EFH1 overexpression. (A)
Venn diagram of 129 genes regulated by EFG1- (EFG1) or EFH1
(EFH1) overexpression. Expression ratios of genes regulated in
strain CAI4[pRC2312P-H] overexpressing EFG1 or in strain
CAI4[pDB35] overexpressing EFH1 relative to a control transfor-
mant (CAI4[pBI-1]) grown identically were determined. Strains
were grown in SCAA medium at 30°C. (B) Clustering of genes
regulated by EFG1/EFH1 overexpression. Genes in sections desig-
nated A1, A2, and B are shown in more detail in Supplemental Data,
Figure 4.
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also suggested by the findings that EFH1 overexpression
phenotypes including pseudohypha- and opaque-white-in-
duction, require Efg1p, and by the synthetic effects of Efh1
and Efg1 upon the C. albicans transcriptome. Thus, our data
suggest that in C. albicans, the relative importance of the
APSES proteins is skewed toward the main regulator Efg1p,
whose role is facilitated under some conditions by the aux-
iliary factor Efh1p. In contrast, the S. cerevisiae APSES pro-
teins seem to have opposing functions. A schematic over-
view of APSES protein functions in C. albicans is shown in
Figure 10.
The influence of an efg1 mutation upon expression of a
limited set of genes, and more recently upon the C. albicans
transcriptome, has been described previously (Lane et al.,
2001; Nantel et al., 2002; Sohn et al., 2003). Our genome-wide
transcript profiling extends these results significantly by 1)
including the second APSES-encoding gene, EFH1; 2) exam-
ining the effects of overexpressing the APSES proteins; 3)
analyzing the importance of APSES proteins at an early
stage of hypha induction; and 4) establishing the role of
APSES proteins in metabolism in addition to morphogene-
sis. Nantel et al. (2002) mainly described differences between
the transcript profiles of cells under noninducing and induc-
ing conditions. In contrast, we have compared mutant and
wild-type cells under the same (inducing or noninducing)
medium to identify even relatively small but statistically
significant changes in the transcript profiles mediated by the
APSES proteins. Also, we used strain CAF2-1 as the wild-
type strain, because it is more directly related to the genetic
background of the mutants we examined.
The inactivation of Efg1p is known to exert strong pheno-
typic effects upon C. albicans (Lo et al., 1997; Stoldt et al.,
1997). Hence, it is not surprising that transcript profiling
revealed that numerous genes were affected by the absence
of Efg1p. In contrast, deletion of EFH1 led to relatively few
changes in the transcriptional profile. However, this was
consistent with the minimal phenotypic effects of the efh1
deletion.
Figure 9. Transcriptional activities of Efg1p and Efh1p in one- or two-
hybrid analyses. (A) One-hybrid assay in C. albicans. Expression plasmids
encoding S. aureus LexA (SaLexA) or LexA-fusions to Efg1p (SaLexA-
Efg1) or Efh1p (SaLexA-Efh1) were transformed into strain CRC104 (105,
106) carrying a lacZ reporter gene under control of a lexA operator (). As
controls strains CRC101 (102, 103), which carry lacZ without a lexA oper-
ator (
), were used as hosts. LacZ activity of cells grown on SD medium
was determined using X-Gal indicator. (B) Two-hybrid assay in S. cerevi-
siae. Genes encoding full-length and truncated versions of Efh1p were
inserted into pGBD- or GAD-vectors to express fusions to the Gal4p-DNA
binding (BD) or activation domain (AD). Pairs of BD- or AD-plasmids
were transformed into S. cerevisiae PJ69-4A;-galactosidase levels of trans-
formants, encoded by a GAL7-lacZ fusion in this strain, were determined
in a liquid assay and expressed as Miller units. The localization of the
APSES-domain in Efh1p, as well as presumed activation (a) and dimer-
ization (d) domains, are indicated.
Figure 10. Model of APSES protein functions in C. albicans. Efg1p
favors the yeast growth form and a fermentative mode of metabo-
lism. It also is required for the transition from the yeast to the
hyphal growth form, which is initiated by inducers including se-
rum. In embedded and hypoxic conditions, at lower temperatures,
Efg1p represses rather than induces hypha formation. Efg1p could
act directly, as a direct transcriptional activator, or indirectly, by
repressing yet undefined repressors of morphogenesis and metab-
olism (as suggested by Efg1p-repressor function in one-hybrid ex-
periments). Efh1p enhances the activation and repression functions
of Efg1p in metabolism and morphogenesis, presumably by activa-
tion of EFG1 expression; Efh1p may also have yet unknown Efg1p-
independent functions.
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When the functions of Efg1-regulated genes were exam-
ined, almost every gene encoding an enzyme involved in
glycolysis was found to be stimulated by Efg1p. In contrast,
genes encoding oxidative enzymes of the citric acid cycle
were repressed by Efg1p. These differences were due to the
loss of Efg1 rather than growth effects, because we examined
the transcriptomes of efg1 and wild-type cells under identi-
cal growth conditions. Thus, the presence of Efg1p favors
fermentative and represses oxidative metabolism. A similar
statement was made recently after comparisons of the tran-
scriptomes of white and opaque cells. Lan et al. (2002) showed
that the white (regular yeast) cells had enhanced expression
of glycolytic genes compared with the opaque (rod-like) cells,
which seemed to be in an state favoring oxidative metabo-
lism. Intriguingly, EFG1 expression is insignificant in opaque
cells, and efg1 mutants have an opaque-like appearance (Son-
neborn et al., 1999b). Therefore, the overlaps between the
transcriptomes of opaque and efg1 cells might be due, at least
in part, to the absence of Efg1p. We show that the effects of
Efg1p disruption upon glycolysis are of biological signifi-
cance, because the growth of efg1 mutants is relatively sen-
sitive to antimycin A, an inhibitor of respiration.
EFG1 and EFH1 overexpression affected the expression of
several genes in common. This was to be expected because
the overexpression of both genes causes similar phenotypes,
including the induction of pseudohyphal growth and pro-
motion of opaque to white phenotypic switching. The induc-
tion of pseudohyphal growth by EFH1 required the presence
of EFG1, suggesting that Efh1p acts indirectly to stimulate
EFG1 expression or Efg1p activity, which consequently
would lead to (partially) overlapping transcriptional pro-
files. Genes commonly regulated by Efg1p- and Efh1p-over-
production included ALS1, ALS10, and HWP1. This is prob-
ably closely correlated to the pseudohyphal or filamentous
growth modes of these cell types (Braun and Johnson, 2000;
Lane et al., 2001). Nevertheless, other genes were differen-
tially regulated by Efg1p and Efh1p, probably reflecting the
structural differences of both proteins. Interestingly, the set
of genes identified in overexpression experiments did not
overlap significantly with genes affected by the absence of
APSES proteins in hypha-inducing conditions. Again, this
highlights that significant differences exist between
pseudohyphal and true hyphal modes of growth. Surpris-
ingly, overexpression of EFG1 and EFH1 down-regulated
IPF5185 (FLO1), encoding a putative yeast-specific cell wall
protein, although in an efg1 mutant it was down-regulated
as well (Nantel et al., 2002; Sohn et al., 2003). This can be
explained by the suggestion that Efg1p acts as an activator
as well as a repressor for this gene (Sohn et al., 2003).
To summarize, the results presented in this study suggest
that APSES proteins are important regulators of metabolism
and morphogenesis in C. albicans. Their effects upon mor-
phogenesis include inducible dimorphism and spontaneous
phenotypic switching. The typical yeast form (white) exploits
a fermentative mode of metabolism, which is enhanced by
the APSES protein Efg1p. This also renders these cells com-
petent to form true hyphae in standard inducing conditions
(lack of glucose, presence of inducers, 37°C). Homozygosity
at the MTL locus, low temperatures (Miller and Johnson,
2002), or the down-regulation of EFG1/EFH1 (Sonneborn et
al., 1999b) allows the generation of the opaque form, which
exploits an oxidative mode of metabolism. This is refractory
to standard inducers of hyphal growth.
We previously pointed out several structural and func-
tional parallels between Efg1p and human myc proteins
(Stoldt et al., 1997; Tebarth et al., 2003). Interestingly, it has
been reported recently that, in addition to its role in cellular
differentiation, myc induces fermentative metabolism (in
particular glucose import and glycolysis: Osthus et al., 2000).
Intriguingly, Myc-like proteins in Drosophila bind to 15%
of all coding regions (Orian et al., 2003) suggesting a general
role in gene expression. Collectively, the data suggest that
APSES proteins play important roles in coordinating central
metabolism with cellular differentiation.
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